Cardiogenic Shock: Outcomes, Treatment, and Role of Hemodynamic Support

Eugenia Nikolsky, Amit Soni, Rafael Beyar

Research output: Chapter in Book/Report/Conference proceedingChapter


Cardiogenic shock (CS) is a leading cause of in-hospital mortality in patients admitted for acute myocardial infarction (AMI). CS is a condition of sustained hypotension requiring administration of catecholamines along with signs of impaired end-organ perfusion. Hemorrhagic shock due to bleeding complications should be strongly considered as a possible reason for shock in patients undergoing pharmacological or mechanical reperfusion. CS in patients with acute coronary syndromes without ST-segment elevation is associated with rates of mortality similar to those in patients with ST-elevation myocardial infarction (STEMI). The main goal of mechanical circulatory support in patients with CS is to improve the hemodynamics and the metabolic condition. CS is a dreadful complication of AMI. Introduction of and advances in revascularization techniques resulted in both decrease in CS incidence and improvement of outcomes.

Original languageEnglish (US)
Title of host publicationUrgent Interventional Therapies
PublisherWiley Blackwell
Number of pages19
ISBN (Print)9781118504499, 9780470672020
StatePublished - Nov 17 2014
Externally publishedYes


  • Acute myocardial infarction (AMI)
  • Cardiogenic shock (CS)
  • Hemodynamic support
  • ST-elevation myocardial infarction (STEMI)

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Cardiogenic Shock: Outcomes, Treatment, and Role of Hemodynamic Support'. Together they form a unique fingerprint.

Cite this